USANA Health Sciences (NYSE:USNA) Sets New 52-Week Low After Earnings Miss

USANA Health Sciences, Inc. (NYSE:USNA) shares hit a new 52-week low on Wednesday following a dissappointing earnings announcement. The company traded as low as $40.51 and last traded at $44.78, with a volume of 14278 shares. The stock had previously closed at $45.96.

The company reported $0.54 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.11). USANA Health Sciences had a return on equity of 11.26% and a net margin of 6.29%. The business had revenue of $212.87 million for the quarter, compared to analysts’ expectations of $218.64 million. During the same quarter in the previous year, the firm earned $0.89 earnings per share.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. DA Davidson dropped their target price on shares of USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Wednesday.

Insider Activity

In other news, CFO G Doug Iiekking sold 5,198 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total transaction of $232,662.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CFO G Doug Iiekking sold 5,198 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $44.76, for a total transaction of $232,662.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Daniel A. Macuga sold 3,791 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $47.14, for a total value of $178,707.74. The disclosure for this sale can be found here. In the last three months, insiders have sold 31,591 shares of company stock worth $1,458,098. 0.33% of the stock is currently owned by insiders.

Institutional Investors Weigh In On USANA Health Sciences

Several institutional investors and hedge funds have recently bought and sold shares of the business. CWM LLC lifted its holdings in USANA Health Sciences by 21.8% in the 1st quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after buying an additional 276 shares during the period. New York State Common Retirement Fund lifted its holdings in USANA Health Sciences by 1.2% in the 4th quarter. New York State Common Retirement Fund now owns 24,500 shares of the company’s stock worth $1,313,000 after buying an additional 279 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in USANA Health Sciences by 9.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock worth $284,000 after buying an additional 494 shares during the period. Strs Ohio lifted its holdings in USANA Health Sciences by 9.2% in the 4th quarter. Strs Ohio now owns 11,900 shares of the company’s stock worth $637,000 after buying an additional 1,000 shares during the period. Finally, Quest Partners LLC purchased a new stake in USANA Health Sciences in the 4th quarter worth approximately $66,000. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Trading Down 6.0 %

The firm has a fifty day simple moving average of $46.27 and a two-hundred day simple moving average of $47.07. The firm has a market cap of $797.05 million, a PE ratio of 13.03, a PEG ratio of 1.38 and a beta of 0.90.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.